在高伤心肌病中进行基因检测.
Catherine G Ireland1, Carolyn Y Ho1
1Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
The American journal of cardiology
|February 17, 2024
概括
基因检测有助于通过识别致病变体来诊断和管理多变性心肌病 (HCM). 这些遗传信息对于准确的诊断,家庭查和个性化的患者护理至关重要.
科学领域:
- 心血管遗传学 心血管遗传学
- 分子诊断学 分子诊断学
背景情况:
- 巨变性心肌病 (HCM) 诊断和管理显著受益于基因检测.
- 鉴定致病性遗传变异是了解疾病机制和遗传模式的关键.
研究的目的:
- 概述基因检测在高性心肌病 (HCM) 中的作用和实用性.
- 讨论基因测试对患者诊断,家庭查和临床管理的影响.
主要方法:
- 审查目前的HCM遗传检测方法.
- 对变种鉴定率及其临床意义的分析.
- 讨论遗传咨询和结果的解释.
主要成果:
- 现代遗传检测可以在30%至60%以上的HCM患者中识别致病变体.
- 测试阳性受到患者特征的影响,例如家庭病史.
- 积极的结果澄清了诊断,并促进了针对性的家庭查.
结论:
- 基因检测是诊断和管理HCM患者及其家属的重要工具.
- 解释遗传测试结果需要专业知识和多学科合作.
- 危险家庭成员的预测测试有助于风险分层和查决策.
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


